NCT04925479
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04925479
Title Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | TUR | POL | NLD | ITA | GRC | FRA | DEU

Facility Status City State Zip Country Details
Indiana UH Riley H for CIU Indianapolis Indiana 46202-5167 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center New York Presbyterian New York New York 10032 United States Details
Novartis Investigative Site Beijing 100044 China Details
Novartis Investigative Site Lille 59000 France Details
Novartis Investigative Site Paris 75019 France Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Genova GE 16147 Italy Details
Novartis Investigative Site Roma RM 00165 Italy Details
Novartis Investigative Site Yokohama Kanagawa 2328555 Japan Details
Novartis Investigative Site Shinjuku-ku Tokyo 1608582 Japan Details
Novartis Investigative Site Osaka 5340021 Japan Details
Novartis Investigative Site Utrecht 3584 CS Netherlands Details
Novartis Investigative Site Wroclaw 50-367 Poland Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Khon Kaen THA 40002 Thailand Details
Novartis Investigative Site Chiang Mai 50200 Thailand Details
Novartis Investigative Site Istanbul Fatih 34093 Turkey (Türkiye) Details
Novartis Investigative Site Bursa Nilufer 16059 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field